dipankar_bhattacharjee_teva

Dipankar Bhattacharjee becomes vice president of Teva Northern Europe

pharmafile | November 21, 2011 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva 

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe.

Teva said that as part of the new European leadership team Dipankar be able to use the experience in the UK to maintain and grow the company’s leadership in the other European markets, which share many characteristics with the UK.

Teva said that the UK is the number one in generics, and the inclusion of the UK within the Northern Europe region will create a ‘strong centre of commercial excellence’.

Related Content

Teva announces positive results from trial of AJOVY for migraine

Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its …

louis-reed-pwckf7l4-no-unsplash_5

Sanofi and Teva partner for development of inflammatory bowel disease treatment

Sanofi and Teva Pharmaceuticals have announced that they will collaborate for the co-development and co-commercialisation …

judge-gavel-1461966002dbr

Teva’s cancer drug Bendeka protected from generics until 2031, judge rules

A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe …

The Gateway to Local Adoption Series

Latest content